Last edition
News about "Civica "
Biocon Biologics and Civica Launch Private-Label Insulin Glargine in the US
The multi-year transformational agreement between Biocon Biologics and Civica creates an exclusive distributorship arrangement where Biocon Biologics will manufacture and supply Insulin Glargine medicine to Civica, and Civica will commercialise under Biocon Biologics’ existing marketing approval.
Civica | 21/10/2025 | By Dineshwori
Biocon Biologics and Civica to Expand Insulin Aspart Access in US
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials. No technology transfer is involved in the agreement.
Civica | 10/03/2025 | By Aishwarya | 261
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy